标题
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
作者
关键词
-
出版物
Frontiers in Immunology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-01-05
DOI
10.3389/fimmu.2017.01825
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer
- (2017) M. Felices et al. GYNECOLOGIC ONCOLOGY
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice
- (2017) Janneke S. Hoogstad-van Evert et al. OncoImmunology
- Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
- (2016) Joerg U Schmohl et al. MOLECULAR THERAPY
- Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker
- (2016) Joerg U. Schmohl et al. Oncotarget
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches
- (2016) Sebastian Carotta Frontiers in Immunology
- Natural Killer Cell Adoptive Transfer Therapy
- (2015) Zachary B. Davis et al. CANCER JOURNAL
- Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
- (2015) Richard W. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Maternal uterine natural killer cells nurture fetal growth: in medio stat virtus
- (2015) Francesco Colucci et al. TRENDS IN MOLECULAR MEDICINE
- Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma
- (2015) Sarka Lukesova et al. Wspolczesna Onkologia-Contemporary Oncology
- Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
- (2015) David L. Hermanson et al. Frontiers in Immunology
- Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
- (2015) Mattias Carlsten et al. Frontiers in Immunology
- B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
- (2015) Silvia Pesce et al. OncoImmunology
- Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy
- (2014) D E Oppenheim et al. BRITISH JOURNAL OF CANCER
- Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
- (2014) E. Schlecker et al. CANCER RESEARCH
- Uterine NK cells: active regulators at the maternal-fetal interface
- (2014) Ashley Moffett et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical and Differential Roles of NKp46- and NKp30-Activating Receptors Expressed by Uterine NK Cells in Early Pregnancy
- (2014) H. El Costa et al. JOURNAL OF IMMUNOLOGY
- Endometrial NK Cells Are Special Immature Cells That Await Pregnancy
- (2014) I. Manaster et al. JOURNAL OF IMMUNOLOGY
- TGF- Utilizes SMAD3 to Inhibit CD16-Mediated IFN- Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells
- (2014) R. Trotta et al. JOURNAL OF IMMUNOLOGY
- Maintenance Therapy With Autologous Cytokine-induced Killer Cells in Patients With Advanced Epithelial Ovarian Cancer After First-line Treatment
- (2014) Jun Liu et al. JOURNAL OF IMMUNOTHERAPY
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Differential Antigen Expression Profile Predicts Immunoreactive Subset of Advanced Ovarian Cancers
- (2014) Kevin H. Eng et al. PLoS One
- Clinical utility of natural killer cells in cancer therapy and transplantation
- (2014) David A. Knorr et al. SEMINARS IN IMMUNOLOGY
- Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer
- (2014) T. Mariya et al. Cancer Immunology Research
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer
- (2013) J. R. Webb et al. CLINICAL CANCER RESEARCH
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- Immunotherapy in ovarian cancer
- (2012) Gina M. Mantia-Smaldone et al. Human Vaccines & Immunotherapeutics
- B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
- (2011) Tomonori Kaifu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity
- (2011) Kory L. Alderson et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Natural Killer Cells and Solid Tumors
- (2011) Ana Stojanovic et al. Journal of Innate Immunity
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
- (2010) D. M. Benson et al. BLOOD
- Cell Death Mechanisms Induced by Cytotoxic Lymphocytes
- (2010) L Chávez-Galán et al. Cellular & Molecular Immunology
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction
- (2010) Sonja Textor et al. INTERNATIONAL JOURNAL OF CANCER
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer
- (2009) Anda M. Vlad et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study
- (2009) Francesco Recchia et al. GYNECOLOGIC ONCOLOGY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Programmed Switch from IL-15- to IL-2-Dependent Activation in Human NK Cells
- (2009) Anne-Hélène Pillet et al. JOURNAL OF IMMUNOLOGY
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- Different regulation of MHC Class I antigen processing components in human tumors
- (2009) Barbara Seliger Journal of Immunotoxicology
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells
- (2008) N. Nausch et al. BLOOD
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
- (2008) David S. Alberts et al. GYNECOLOGIC ONCOLOGY
- Negative signaling by inhibitory receptors: the NK cell paradigm
- (2008) Eric O. Long IMMUNOLOGICAL REVIEWS
- Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model
- (2008) Hwan Mook Kim et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer
- (2008) Sonja Textor et al. INTERNATIONAL JOURNAL OF CANCER
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function
- (2008) Venkateswara Rao Simhadri et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started